Singapore Research Antibodies Market Size & Outlook
The research antibodies market in Singapore is expected to reach a projected revenue of US$ 88.0 million by 2033. A compound annual growth rate of 10.2% is expected of Singapore research antibodies market from 2026 to 2033.
- Biotechnology
- Antibody Production
- Research Antibodies Market Outlook
- Antibody Production
Revenue, 2025 (US$M)
$40.8
Estimate, 2026 (US$M)
$44.4
Forecast, 2033 (US$M)
$88.0
CAGR, 2026 - 2033
10.2%
Global Market
Related Markets
Ask Prism AI anything about the research antibodies market
Get a cited answer from GVR research in seconds: segment shares, growth drivers, regulation and forecast assumptions.
Every answer starts with GVR research, and every figure is cited.Explore Prism AI
Singapore research antibodies market highlights
- The Singapore research antibodies market generated a revenue of USD 40.8 million in 2025 and is expected to reach USD 88.0 million by 2033.
- The Singapore market is expected to grow at a CAGR of 10.2% from 2026 to 2033.
- In terms of segment, monoclonal antibodies was the largest revenue generating specificity in 2025.
- Monoclonal Antibodies is the most lucrative specificity segment registering the fastest growth during the forecast period.
Research antibodies market data book summary
| Market revenue in 2025 | USD 40.8 million |
| Market revenue in 2033 | USD 88.0 million |
| Growth rate | 10.2% (CAGR from 2026 to 2033) |
| Largest segment | Monoclonal antibodies |
| Fastest growing segment | Monoclonal Antibodies |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Polyclonal Antibodies, Monoclonal Antibodies |
| Key market players worldwide | Abcam PLC, Merck KGaA, Thermo Fisher Scientific Inc, Cell Signaling Technology, PerkinElmer, Becton Dickinson & Co, Bio-Techne Corp, Proteintech Group |
Other key industry trends
- In terms of revenue, Singapore accounted for 2.1% of the global research antibodies market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Asia Pacific, China research antibodies market is projected to lead the regional market in terms of revenue in 2033.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 219.6 million by 2033.
No credit card required*
Publish Date: Jun 22, 2026
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
- Turnaround
- 5–10 working days
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Research Antibodies Market Scope
Research Antibodies Market segmentation & scope
Research Antibodies Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Merck KGaA | View profile | 62,345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | www.emdgroup.com |
| Becton Dickinson & Co | View profile | 73,000 | 1 Becton Drive, Franklin Lakes, NJ, United States, 07417-1880 | www.bd.com |
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Bio-Techne Corp | View profile | 3,050 | 614 McKinley Place N.E., Minneapolis, MN, United States, 55413 | www.bio-techne.com |
| Abcam PLC | View profile | 1,760 | Discovery Drive, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AX | www.abcam.com |
| PerkinElmer | View profile | 10001+ | Waltham, Massachusetts, United States, North America | www.perkinelmer.com |
| Proteintech Group | View profile | 251-500 | Rosamond, Illinois, United States, North America | www.ptglab.com |
| Cell Signaling Technology | View profile | 501-1000 | Danvers, Massachusetts, United States, North America | www.cellsignal.com |
Singapore Research Antibodies Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Research Antibodies Market Outlook will help companies and investors design strategic landscapes.
Monoclonal Antibodies was the largest segment with a revenue share of 65.44% in 2025.
Horizon Databook has segmented the Singapore research antibodies market based on polyclonal antibodies, monoclonal antibodies covering the revenue growth of each sub-segment from 2021 to 2033.
- Singapore Research Antibodies Market Specificity Outlook (Revenue, USD Million , 2021-2033)
- Polyclonal Antibodies
- Monoclonal Antibodies
- Singapore Research Antibodies Market Product Outlook (Revenue, USD Million , 2021-2033)
- Primary
- Secondary
- Singapore Research Antibodies Market Technology Outlook (Revenue, USD Million , 2021-2033)
- Western blotting
- Flow cytometry
- Immunofluorescence
- Immunohistochemistry
- Immunoprecipitation
- ELISA
- Others Technology
- Singapore Research Antibodies Market Source Outlook (Revenue, USD Million , 2021-2033)
- Rabbit
- Goat
- Mice
- Others Source
- Singapore Research Antibodies Market Applications Outlook (Revenue, USD Million , 2021-2033)
- Oncology
- Stem Cells
- Others Applications
- Infectious Diseases
- Immunology
- Neurobiology
- Singapore Research Antibodies Market End Use Outlook (Revenue, USD Million , 2021-2033)
- Contract Research Organizations
- Pharma & Biotech Companies
- Academic & Research Institutes
Reasons to subscribe to Research Antibodies Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Research Antibodies Market Outlook databook
- Our clientele includes a mix of Research Antibodies Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Singapore Research Antibodies Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Singapore Research Antibodies Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Singapore Research Antibodies Market, 2021-2033 (US$M)
Singapore research antibodies market statistics, by specificity, 2021-2033 (US$M)
